BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 125465)

  • 1. A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.
    Collen D; De Cock F
    Thromb Res; 1975 Jul; 7(1):235-8. PubMed ID: 125465
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitors.
    Collen D
    Thromb Res; 1974 Dec; 5(6):777-9. PubMed ID: 4280636
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
    Iijima K
    Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systems.
    Collen D
    Acta Clin Belg; 1977; 32(6):398-402. PubMed ID: 151470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the process of fibrinogen breakdown by plasmin. II. Relationship between serial thrombin time and plasma antithrombin or antiplasmin].
    Shinada S
    Nihon Naika Gakkai Zasshi; 1970 Sep; 59(9):959-66. PubMed ID: 4248531
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 8. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
    Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 10. The coagulation system is activated in idiopathic cardiomyopathy.
    Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
    J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery].
    Fukuda C; Iijima K; Inoue N; Takashima Y; Urabe C; Nakamura K
    Rinsho Byori; 1988 Mar; 36(3):346-50. PubMed ID: 2969986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The coagulation and fibrinolytic properties of rabbit erythrocytes].
    Potekhin KG; Nikitin IuP; Fedenkov VI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1972; 3(99):47-51. PubMed ID: 4265540
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
    Fuse Y; Fuse K
    Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel immunoenzyme assays for thrombin-antithrombin III and thrombin-alpha 2-macroglobulin complexes in plasma.
    Harpel PC; Fenton JW
    Ann N Y Acad Sci; 1986; 485():184-98. PubMed ID: 2436524
    [No Abstract]   [Full Text] [Related]  

  • 17. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
    Itoh N
    Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha 2-plasmin inhibitor-plasmin complex].
    Yoshikawa Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():685-7. PubMed ID: 10543213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.